Breast cancer
Conditions
Interventions
Control Group:The treatment regimen for the control group follows the Guidelines for the Diagnosis and Treatment of Breast Cancer of the Chinese Anti-Cancer Association. Postoperatively, chemotherapy
Treatment group:The treatment group received oral administration of Wenshen Shengbai Decoction in addition to the chemotherapy regimen given to the control group. The herbal decoction was uniformly pr
Sponsors
Yueyang Hospital of integrated Traditionel Chineseand Western Medicine, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Female, aged =18 years and =70 years; (2) Malignant tumor originating from breast tissue, pathologically diagnosed as breast cancer; (3) Patients requiring adjuvant chemotherapy with the (Epirubicin, Cyclophosphamide) regimen based on pathological findings and in accordance with the Guidelines for the Diagnosis and Treatment of Breast Cancer of the Chinese Anti-Cancer Association; (4) Signed informed consent; (5) Meeting the diagnostic criteria for Yang deficiency pattern in traditional Chinese medicine.
Exclusion criteria
Exclusion criteria: (1) Patients with other breast malignancies such as breast sarcoma, malignant lymphoma of the breast, etc., or those with other primary malignant tumors, tuberculosis, or underlying diseases that may affect the study outcomes; (2) Patients complicated with severe heart failure, renal failure, liver disease, or mental disorders that may affect the treatment and evaluation of the disease; (3) Pregnant or lactating women; (4) Patients allergic to Wenshen Shengbai Decoction; (5) Patients who have already participated in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| White blood cell count; | — |
Secondary
| Measure | Time frame |
|---|---|
| Absolute neutrophil count;Platelet Count;Hemoglobin Count;Neutrophil count;Patient's rhG-CSF usage;Interleukin-2;Interleukin-1ß;Interleukin-6;Interleukin-8;Interleukin-10;Interferon-alpha;Interferon-?;Tumor Necrosis Factor;C-reactive protein; | — |
Countries
China
Contacts
Public ContactXiaohong Xue
Yueyang Hospital of integrated Traditionel Chineseand Western Medicine, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed